Literature DB >> 28009282

Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation.

Ryan J Delahanty1, Yanfeng Zhang2, Terry Jo Bichell3, Wangzhen Shen3, Kelienne Verdier3, Robert L Macdonald4, Lili Xu3, Kelli Boyd5, Janice Williams6, Jing-Qiong Kang7.   

Abstract

Reduced ocular pigmentation is common in Angelman syndrome (AS) and Prader-Willi syndrome (PWS) and is long thought to be caused by OCA2 deletion. GABRB3 is located in the 15q11-13 region flanked by UBE3A, GABRA5, GABRG3, and OCA2. Mutations in GABRB3 have frequently been associated with epilepsy and autism, consistent with its role in neurodevelopment. We report here a robust phenotype in the mouse in which deletion of Gabrb3 alone causes nearly complete loss of retinal pigmentation due to atrophied melanosomes, as evidenced by electron microscopy. Using exome and RNA sequencing, we confirmed that only the Gabrb3 gene was disrupted while the Oca2 gene was intact. However, mRNA abundance of Oca2 and other genes adjacent to Gabrb3 is substantially reduced in Gabrb3-/- mice, suggesting complex transcriptional regulation in this region. These results suggest that impairment in GABRB3 downregulates OCA2 and indirectly causes ocular hypopigmentation and visual defects in AS and PWS.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angelman syndrome; GABA(A) receptors; GABRB3; OCA2; UBE3A; autism; deletion; epilepsy; eye; hypopigmentation

Mesh:

Substances:

Year:  2016        PMID: 28009282      PMCID: PMC5240804          DOI: 10.1016/j.celrep.2016.11.067

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  26 in total

1.  Origin of uniparental disomy 15 in patients with Prader-Willi or Angelman syndrome.

Authors:  C Fridman; C P Koiffmann
Journal:  Am J Med Genet       Date:  2000-09-18

2.  Ophthalmic findings in Angelman syndrome.

Authors:  Paola Michieletto; Paolo Bonanni; Stefano Pensiero
Journal:  J AAPOS       Date:  2011-04       Impact factor: 1.220

Review 3.  GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man.

Authors:  T M DeLorey; R W Olsen
Journal:  Epilepsy Res       Date:  1999-09       Impact factor: 3.045

Review 4.  Molecular and clinical study of 61 Angelman syndrome patients.

Authors:  S Saitoh; N Harada; Y Jinno; K Hashimoto; K Imaizumi; Y Kuroki; Y Fukushima; T Sugimoto; M Renedo; J Wagstaff
Journal:  Am J Med Genet       Date:  1994-08-15

5.  Altered GABAA receptor expression in brainstem nuclei and SUDEP in Gabrg2(+/Q390X) mice associated with epileptic encephalopathy.

Authors:  Geqing Xia; Sarah P Pourali; Timothy A Warner; Chun-Qing Zhang; Robert L Macdonald; Jing-Qiong Kang
Journal:  Epilepsy Res       Date:  2016-04-13       Impact factor: 3.045

6.  Differential molecular and behavioural alterations in mouse models of GABRG2 haploinsufficiency versus dominant negative mutations associated with human epilepsy.

Authors:  Timothy A Warner; Wangzhen Shen; Xuan Huang; Zhong Liu; Robert L Macdonald; Jing-Qiong Kang
Journal:  Hum Mol Genet       Date:  2016-06-23       Impact factor: 6.150

7.  Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

Authors:  Y H Jiang; D Armstrong; U Albrecht; C M Atkins; J L Noebels; G Eichele; J D Sweatt; A L Beaudet
Journal:  Neuron       Date:  1998-10       Impact factor: 17.173

8.  A strong promoter element is located between alternative exons of a gene encoding the human gamma-aminobutyric acid-type A receptor beta 3 subunit (GABRB3).

Authors:  E F Kirkness; C M Fraser
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

9.  A variety of genetic mechanisms are associated with the Prader-Willi syndrome.

Authors:  T Woodage; Z M Deng; M Prasad; R Smart; R Lindeman; S L Christian; D H Ledbetter; L Robson; A Smith; R J Trent
Journal:  Am J Med Genet       Date:  1994-09-15

10.  Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.

Authors:  T M DeLorey; A Handforth; S G Anagnostaras; G E Homanics; B A Minassian; A Asatourian; M S Fanselow; A Delgado-Escueta; G D Ellison; R W Olsen
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

View more
  3 in total

1.  Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.

Authors:  Yi-Wu Shi; Qi Zhang; Kefu Cai; Sarah Poliquin; Wangzhen Shen; Nathan Winters; Yong-Hong Yi; Jie Wang; Ningning Hu; Robert L Macdonald; Wei-Ping Liao; Jing-Qiong Kang
Journal:  Brain       Date:  2019-10-01       Impact factor: 13.501

Review 2.  Genetic and molecular biology of autism spectrum disorder among Middle East population: a review.

Authors:  Zahra Rahmani; Mohammad Reza Fayyazi Bordbar; Mohsen Dibaj; Maliheh Alimardani; Meysam Moghbeli
Journal:  Hum Genomics       Date:  2021-03-12       Impact factor: 4.639

Review 3.  Epigenetics in Prader-Willi Syndrome.

Authors:  Aron Judd P Mendiola; Janine M LaSalle
Journal:  Front Genet       Date:  2021-02-15       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.